Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Feunteun

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Plos Genetics|March 4, 2016
Role of the BAHD1 Chromatin-Repressive Complex in Placental Development and Regulation of Steroid MetabolismGoran Lakisic, Alice Lebreton, Renaud Pourpre, et al.
Molecular Cancer Research : MCR|September 28, 2018
Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of <i>BRCA1</i> BRCT Variants on Cancer RiskAmbre Petitalot, Elodie Dardillac, Eric Jacquet, et al.
Haematologica|September 22, 2011
Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemiaCharline Ladroue, David Hoogewijs, Sophie Gad, et al.
Science Translational Medicine|December 16, 2016
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor geneLéon C L van Kempen, Margaret Redpath, Mounib Elchebly, et al.
Cancer Research|November 6, 2014
Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesisSophie Couvé, Charline Ladroue, Elodie Laine, et al.
Biological Reviews of the Cambridge Philosophical Society|May 9, 2023
Reuniting philosophy and science to advance cancer researchThomas Pradeu, Bertrand Daignan-Fornier, Andrew Ewald, et al.
Journal of Medical Genetics|June 9, 2017
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcomaFanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, et al.
Journal of Medical Genetics|March 15, 2011
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinomaBetty Gardie, Audrey Remenieras, Darouna Kattygnarath, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Plos Genetics|March 4, 2016
Role of the BAHD1 Chromatin-Repressive Complex in Placental Development and Regulation of Steroid MetabolismGoran Lakisic, Alice Lebreton, Renaud Pourpre, et al.
Molecular Cancer Research : MCR|September 28, 2018
Combining Homologous Recombination and Phosphopeptide-binding Data to Predict the Impact of <i>BRCA1</i> BRCT Variants on Cancer RiskAmbre Petitalot, Elodie Dardillac, Eric Jacquet, et al.
Haematologica|September 22, 2011
Distinct deregulation of the hypoxia inducible factor by PHD2 mutants identified in germline DNA of patients with polycythemiaCharline Ladroue, David Hoogewijs, Sophie Gad, et al.
Science Translational Medicine|December 16, 2016
The protein phosphatase 2A regulatory subunit PR70 is a gonosomal melanoma tumor suppressor geneLéon C L van Kempen, Margaret Redpath, Mounib Elchebly, et al.
Cancer Research|November 6, 2014
Genetic evidence of a precisely tuned dysregulation in the hypoxia signaling pathway during oncogenesisSophie Couvé, Charline Ladroue, Elodie Laine, et al.
Biological Reviews of the Cambridge Philosophical Society|May 9, 2023
Reuniting philosophy and science to advance cancer researchThomas Pradeu, Bertrand Daignan-Fornier, Andrew Ewald, et al.
Journal of Medical Genetics|June 9, 2017
Germline <i>CDKN2A</i>/P16INK4A mutations contribute to genetic determinism of sarcomaFanélie Jouenne, Isaure Chauvot de Beauchene, Emeline Bollaert, et al.
Journal of Medical Genetics|March 15, 2011
Novel FH mutations in families with hereditary leiomyomatosis and renal cell cancer (HLRCC) and patients with isolated type 2 papillary renal cell carcinomaBetty Gardie, Audrey Remenieras, Darouna Kattygnarath, et al.
Pageof 4